Diane Harper, M.D., MPH, M.S., professor of family medicine at Michigan Medicine, has been named physician director for Community Outreach, Engagement and Health Disparities at the University of Michigan Rogel Cancer Center. She will lead the establishment of a community outreach engagement committee to build relationships with the community and seek input from community leaders.
When PGE2 is out of balance and the body makes too much, it can lead to inflammation and to conditions such as cancer and heart disease. Other fatty acids, particularly omega-3 fatty acids, reduce the amount of omega-6 fatty acids available in a cell. This is a key system that controls how much PGE2 the cell makes
Every kind of cancer can spread to the spine, yet two physician-scientists who treat these patients describe a lack of guidance for effectively providing care and minimizing pain.
In an article in U.S. News and World Report, Reshma Jagsi, M.D., D.Phil., describes recent advances in radiation therapy to treat breast cancer.
Cancerous cells are known activate an enzyme called telomerase, causing the cells to divide ceaselessly, a hallmark of cancer. Now, University of Michigan researchers have identified a region on a protein called TPP1 that binds this enzyme, which could provide a target for anticancer drugs.
Researchers found that 1 in 7 patients undergoing lung cancer surgery became new persistent opioid users after surgery, establishing opioid dependence as a postoperative complication that is as common as others, including atrial fibrillation.
The Wall Street Journal looks at efforts to improve how oncologists determine which patients need chemotherapy. What once was a crucial part of cancer treatment might now be best avoided for some patients at low risk. The article cites research from U-M Rogel Cancer Center member Steven Katz, M.D., MPH.
Researchers at the University of Michigan Rogel Cancer Center uncovered a novel gene they named THOR while investigating previously unexplored regions of the human genome -- or the human genome’s dark matter.
After defining the scope of sexual harassment in medicine, a physician says sharing stories and a national reckoning offer hope for progress.
Most cancer immunotherapy research has targeted effector T cells, but a new study steps back and considers: What if the problem isn’t with the effector T cells, but starts higher up the cellular chain? And so researchers looked at naive T cells -- a type of immune cell that hasn’t yet been triggered to fight.